Q4-FY26 · J. Lakshman Rao
We are aiming at at least 210 crores EBITDA for next financial year up from 173. That's a 20% rise.
Mold Tek Packaging · tone and specificity signals across the available quarters.
Language signals
We are aiming at at least 210 crores EBITDA for next financial year up from 173. That's a 20% rise.
Pharma has grown by 37% over the Q4 of last year and overall growth of the full year is more than 200%.
We are in fact finding our clients coming back in hordes because they worried about the connectivity material procurement abilities.